Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2025 10:05 ET | Source: Wohl & Fruchter LLP

OPTN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of OptiNose, to Paratek Pharmaceuticals

We are investigating the fairness of the sale of OptiNose to Paratek Pharmaceuticals for $9.00 per share in cash plus a CVR.